<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The therapeutic effect and laboratory finding in the treatment of 288 cases of ischemic cerebrovascular disease with <z:chebi fb="17" ids="53277">PSS</z:chebi> were analysed </plain></SENT>
<SENT sid="1" pm="."><plain>Positive therapeutic response to <z:chebi fb="17" ids="53277">PSS</z:chebi> in this series of cases was obtained in 92.0% and 62.2% of the treated cases showed excellent results </plain></SENT>
<SENT sid="2" pm="."><plain>Effects in the treated patients were better than in the controls </plain></SENT>
<SENT sid="3" pm="."><plain>The laboratory findings showed that <z:chebi fb="17" ids="53277">PSS</z:chebi> had obvious <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> effect and decreased blood viscosity and serum contents of <z:chebi fb="23" ids="18059">lipids</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The results of animal experiments showed that <z:chebi fb="17" ids="53277">PSS</z:chebi> had the action of blood dilution, lowering blood viscosity and ameliorating hypercoagulation </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="17" ids="53277">PSS</z:chebi> was considered to be a prospective, useful drug to prevent and treat ischemic cerebrovascular disease </plain></SENT>
</text></document>